메뉴 건너뛰기




Volumn 14, Issue 4, 2005, Pages 747-760

Screening for prostate cancer: Opportunities and challenges

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FINASTERIDE; HORMONE;

EID: 26844520051     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2005.07.001     Document Type: Review
Times cited : (9)

References (56)
  • 4
    • 0041977276 scopus 로고    scopus 로고
    • Ten-year survival in patients with metastatic prostate cancer
    • C.M. Tangen, J.R. Faulker, and E.D. Crawford Ten-year survival in patients with metastatic prostate cancer Clin Prostate Cancer 2 2003 41 45
    • (2003) Clin Prostate Cancer , vol.2 , pp. 41-45
    • Tangen, C.M.1    Faulker, J.R.2    Crawford, E.D.3
  • 5
    • 0041830469 scopus 로고    scopus 로고
    • Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control
    • H.K. Weir, M.J. Thun, and B.F. Hankey Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 95 2003 1276 1299
    • (2003) J Natl Cancer Inst , vol.95 , pp. 1276-1299
    • Weir, H.K.1    Thun, M.J.2    Hankey, B.F.3
  • 6
    • 0037454282 scopus 로고    scopus 로고
    • Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence?
    • B.E. Sirovich, L.M. Schwartz, and S. Woloshin Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 289 2003 1414 1420
    • (2003) JAMA , vol.289 , pp. 1414-1420
    • Sirovich, B.E.1    Schwartz, L.M.2    Woloshin, S.3
  • 7
    • 0037812658 scopus 로고    scopus 로고
    • The influence of finasteride on the development of prostate cancer
    • I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 3 2003 215 224
    • (2003) N Engl J Med , vol.349 , Issue.3 , pp. 215-224
    • Thompson, I.M.1    Goodman, P.J.2    Tangen, C.M.3
  • 8
    • 15744390994 scopus 로고    scopus 로고
    • Estimated impact of the Prostate Cancer Prevention Trial on population mortality
    • J.M. Unger, I.M. Thompson Jr., and M. LeBlanc Estimated impact of the Prostate Cancer Prevention Trial on population mortality Cancer 103 7 2005 1375 1380
    • (2005) Cancer , vol.103 , Issue.7 , pp. 1375-1380
    • Unger, J.M.1    Thompson Jr., I.M.2    Leblanc, M.3
  • 9
    • 0021176184 scopus 로고
    • Adenocarcinoma of the prostate: Results of routine urological screening
    • I.M. Thompson, J.J. Ernst, and M.P. Gangai Adenocarcinoma of the prostate: results of routine urological screening J Urol 132 1984 690 692
    • (1984) J Urol , vol.132 , pp. 690-692
    • Thompson, I.M.1    Ernst, J.J.2    Gangai, M.P.3
  • 10
    • 0021745958 scopus 로고
    • Early detection of prostate cancer by routine screening
    • G.W. Chodak, and H.W. Schoenberg Early detection of prostate cancer by routine screening JAMA 252 23 1984 3261 3264
    • (1984) JAMA , vol.252 , Issue.23 , pp. 3261-3264
    • Chodak, G.W.1    Schoenberg, H.W.2
  • 11
    • 0014837076 scopus 로고
    • Precipitating antigens of the normal human prostate
    • R.J. Ablin, W.A. Soanes, and P. Bronson Precipitating antigens of the normal human prostate J Reprod Fertil 22 1970 573 574
    • (1970) J Reprod Fertil , vol.22 , pp. 573-574
    • Ablin, R.J.1    Soanes, W.A.2    Bronson, P.3
  • 12
    • 0015095890 scopus 로고
    • Some physicochemical characteristics of "seminoprotein," an antigenic component specific for human seminal plasma
    • Hara M, Koyanagi Y, Inoue T. et al. Some physicochemical characteristics of "seminoprotein," an antigenic component specific for human seminal plasma. Nippon Hoigaku Zasshi 1971;25:322.
    • (1971) Nippon Hoigaku Zasshi , vol.25 , pp. 322
    • Hara, M.1    Koyanagi, Y.2    Inoue, T.3
  • 13
    • 0015579814 scopus 로고
    • Isolation and characterization of two specific antigens of human seminal plasma
    • T.S. Li, and C.G. Beling Isolation and characterization of two specific antigens of human seminal plasma Fertil Steril 24 1973 134
    • (1973) Fertil Steril , vol.24 , pp. 134
    • Li, T.S.1    Beling, C.G.2
  • 14
    • 0018595985 scopus 로고
    • Purification of a human prostate specific antigen
    • M.C. Wang, L.A. Valenzuela, and G.P. Murphy Purification of a human prostate specific antigen Invest Urol 17 1979 159 163
    • (1979) Invest Urol , vol.17 , pp. 159-163
    • Wang, M.C.1    Valenzuela, L.A.2    Murphy, G.P.3
  • 15
    • 0023141473 scopus 로고
    • An evaluation of prostate specific antigen in prostatic cancer
    • P. Guinan, R. Bhatti, and P. Ray An evaluation of prostate specific antigen in prostatic cancer J Urol 137 1987 686 689
    • (1987) J Urol , vol.137 , pp. 686-689
    • Guinan, P.1    Bhatti, R.2    Ray, P.3
  • 16
    • 0023233060 scopus 로고
    • Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
    • T.A. Stamey, N. Yang, and A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 15 1987 909 916
    • (1987) N Engl J Med , vol.317 , Issue.15 , pp. 909-916
    • Stamey, T.A.1    Yang, N.2    Hay, A.R.3
  • 17
    • 0025849053 scopus 로고
    • Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
    • W. Catalona, D. Smith, and T. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 17 1991 1156 1161
    • (1991) N Engl J Med , vol.324 , Issue.17 , pp. 1156-1161
    • Catalona, W.1    Smith, D.2    Ratliff, T.3
  • 18
    • 0027278621 scopus 로고
    • Screening for prostatic carcinoma with prostate specific antigen: Results of the second year
    • M.K. Brawer, J. Beatie, and M.H. Wener Screening for prostatic carcinoma with prostate specific antigen: results of the second year J Urol 150 1 1993 106 109
    • (1993) J Urol , vol.150 , Issue.1 , pp. 106-109
    • Brawer, M.K.1    Beatie, J.2    Wener, M.H.3
  • 19
    • 0026514819 scopus 로고
    • Screening for prostatic carcinoma with prostate specific antigen
    • M.K. Brawer, M.P. Chetner, and J. Beatie Screening for prostatic carcinoma with prostate specific antigen J Urol 147 3 Pt 2 1992 841 845
    • (1992) J Urol , vol.147 , Issue.3 PART 2 , pp. 841-845
    • Brawer, M.K.1    Chetner, M.P.2    Beatie, J.3
  • 20
    • 0022997241 scopus 로고
    • Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer
    • T.Y. Wang, and T.P. Kawaguchi Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer Ann Clin Lab Sci 16 6 1986 461 466
    • (1986) Ann Clin Lab Sci , vol.16 , Issue.6 , pp. 461-466
    • Wang, T.Y.1    Kawaguchi, T.P.2
  • 21
    • 0025295790 scopus 로고
    • Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen
    • W.H. Cooner, B.R. Mosley, and C.L. Rutherford Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen J Urol 143 6 1990 1146 1152
    • (1990) J Urol , vol.143 , Issue.6 , pp. 1146-1152
    • Cooner, W.H.1    Mosley, B.R.2    Rutherford, C.L.3
  • 22
    • 0027979444 scopus 로고
    • Utilization of polyclonal serum prostate specific antigen levels in screening for prostate cancer: A comparison with corresponding monoclonal values
    • M.K. Terris, and T.A. Stamey Utilization of polyclonal serum prostate specific antigen levels in screening for prostate cancer: a comparison with corresponding monoclonal values Br J Urol 73 1 1993 61 64
    • (1993) Br J Urol , vol.73 , Issue.1 , pp. 61-64
    • Terris, M.K.1    Stamey, T.A.2
  • 23
    • 0024393833 scopus 로고
    • Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
    • K.K. Hodge, J.E. McNeal, and M.K. Terris Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1989 71 75
    • (1989) J Urol , vol.142 , pp. 71-75
    • Hodge, K.K.1    McNeal, J.E.2    Terris, M.K.3
  • 24
    • 0033992452 scopus 로고    scopus 로고
    • The optimal systematic prostate biopsy strategy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
    • J.C. Presti, J.J. Chang, and V. Bhargava The optimal systematic prostate biopsy strategy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial J Urol 163 1 2000 163 166 [discussion, 166-7]
    • (2000) J Urol , vol.163 , Issue.1 , pp. 163-166
    • Presti, J.C.1    Chang, J.J.2    Bhargava, V.3
  • 25
    • 0037213861 scopus 로고    scopus 로고
    • Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: Results of a community multi-practice study
    • J.C. Presti Jr., G.J. O'Dowd, and M.C. Miller Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study J Urol 169 1 2003 125 129
    • (2003) J Urol , vol.169 , Issue.1 , pp. 125-129
    • Presti Jr., J.C.1    O'Dowd, G.J.2    Miller, M.C.3
  • 26
    • 0028865113 scopus 로고
    • Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
    • J.W. Moul, I.A. Sesterrhenn, and R.R. Connelly Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men JAMA 274 16 1995 1277 1281
    • (1995) JAMA , vol.274 , Issue.16 , pp. 1277-1281
    • Moul, J.W.1    Sesterrhenn, I.A.2    Connelly, R.R.3
  • 27
    • 0345009757 scopus 로고    scopus 로고
    • Age specific PSA levels in African Americans
    • K.A. McCammon, P.F. Schellhammer, and G.L. Wright Age specific PSA levels in African Americans [abstract 461] J Urol 155 1996 426
    • (1996) J Urol , vol.155 , pp. 426
    • McCammon, K.A.1    Schellhammer, P.F.2    Wright, G.L.3
  • 28
    • 0026522840 scopus 로고
    • Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
    • H.B. Carter, J.D. Pearson, and E.J. Metter Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease JAMA 267 16 1992 2215 2220
    • (1992) JAMA , vol.267 , Issue.16 , pp. 2215-2220
    • Carter, H.B.1    Pearson, J.D.2    Metter, E.J.3
  • 29
    • 0028787237 scopus 로고
    • Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostate-specific antigen velocity
    • H.B. Carter, J.D. Pearson, and Z. Waclawiw Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity Urology 45 4 1995 591 596
    • (1995) Urology , vol.45 , Issue.4 , pp. 591-596
    • Carter, H.B.1    Pearson, J.D.2    Waclawiw, Z.3
  • 30
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • A.V. D'Amico, M.H. Chen, and K.A. Roehl Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy N Engl J Med 351 2 2004 125 135
    • (2004) N Engl J Med , vol.351 , Issue.2 , pp. 125-135
    • D'Amico, A.V.1    Chen, M.H.2    Roehl, K.A.3
  • 31
    • 1242341917 scopus 로고    scopus 로고
    • Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam
    • R. Raaijmakers, M.F. Wildhagen, and K. Ito Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam Urology 63 2 2004 316 320
    • (2004) Urology , vol.63 , Issue.2 , pp. 316-320
    • Raaijmakers, R.1    Wildhagen, M.F.2    Ito, K.3
  • 32
    • 0026536328 scopus 로고
    • The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen
    • M.C. Benson, I.S. Whang, and C.A. Olsson The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen J Urol 147 3 Pt 2 1992 817 821
    • (1992) J Urol , vol.147 , Issue.3 PART 2 , pp. 817-821
    • Benson, M.C.1    Whang, I.S.2    Olsson, C.A.3
  • 33
    • 0028073510 scopus 로고
    • Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves
    • W.J. Catalona, J.P. Richie, and J.B. deKernion Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves J Urol 152 6 Pt 1 1994 2031 2036
    • (1994) J Urol , vol.152 , Issue.6 PART 1 , pp. 2031-2036
    • Catalona, W.J.1    Richie, J.P.2    Dekernion, J.B.3
  • 34
    • 0027265780 scopus 로고
    • The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma
    • M.K. Brawer, E.A. Aramburu, and G.L. Chen The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma J Urol 150 2 Pt 1 1993 369 373
    • (1993) J Urol , vol.150 , Issue.2 PART 1 , pp. 369-373
    • Brawer, M.K.1    Aramburu, E.A.2    Chen, G.L.3
  • 35
    • 0033119703 scopus 로고    scopus 로고
    • Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: Critical analysis of two different test populations
    • R.W. Veltri, and M.C. Miller Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations Urology 53 1999 736
    • (1999) Urology , vol.53 , pp. 736
    • Veltri, R.W.1    Miller, M.C.2
  • 36
    • 0033916382 scopus 로고    scopus 로고
    • Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
    • W.J. Catalona, P.C. Southwick, and K.M. Slawin Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging Urology 56 2000 255
    • (2000) Urology , vol.56 , pp. 255
    • Catalona, W.J.1    Southwick, P.C.2    Slawin, K.M.3
  • 38
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level ≤ 4.0 ng per milliliter
    • I.M. Thompson, D.K. Pauler, and P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level ≤ 4.0 ng per milliliter N Engl J Med 350 22 2004 2239 2246
    • (2004) N Engl J Med , vol.350 , Issue.22 , pp. 2239-2246
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3
  • 39
    • 21444447966 scopus 로고    scopus 로고
    • Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
    • I.M. Thompson, D.P. Ankerst, and C. Chi Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower JAMA 294 2005 66 70
    • (2005) JAMA , vol.294 , pp. 66-70
    • Thompson, I.M.1    Ankerst, D.P.2    Chi, C.3
  • 40
    • 26844540028 scopus 로고    scopus 로고
    • Prostate cancer detection rate and frequency of Gleason score ≥ 7 in men with PSA levels below 3 ng/ml
    • W. Horninger, A.P. Berger, and A. Pelzer Prostate cancer detection rate and frequency of Gleason score ≥ 7 in men with PSA levels below 3 ng/ml [abstract] J Urol 173 2005 147
    • (2005) J Urol , vol.173 , pp. 147
    • Horninger, W.1    Berger, A.P.2    Pelzer, A.3
  • 41
    • 26844529327 scopus 로고    scopus 로고
    • Baseline SA compared with median PSA for age group as predictor of pathologic tumor features in men < 60 years of age
    • S. Loeb, K.A. Roehl, and J.A.V. Antenor Baseline SA compared with median PSA for age group as predictor of pathologic tumor features in men < 60 years of age J Urol 173 2005 145A
    • (2005) J Urol , vol.173
    • Loeb, S.1    Roehl, K.A.2    Antenor, J.A.V.3
  • 43
    • 0027817294 scopus 로고
    • Prostate cancer awareness week, 1992: A summary of key findings
    • E. DeAntoni, E.D. Crawford, and N.N. Stone Prostate cancer awareness week, 1992: a summary of key findings [review] Clin Invest Med 16 6 1993 448 457
    • (1993) Clin Invest Med , vol.16 , Issue.6 , pp. 448-457
    • Deantoni, E.1    Crawford, E.D.2    Stone, N.N.3
  • 44
    • 0030657827 scopus 로고    scopus 로고
    • Eight years of prostate cancer awareness week: Lessons in screening and early detection. Prostate Cancer Education Council
    • E.P. DeAntoni Eight years of prostate cancer awareness week: lessons in screening and early detection. Prostate Cancer Education Council Cancer 80 9 1997 1845 1851
    • (1997) Cancer , vol.80 , Issue.9 , pp. 1845-1851
    • Deantoni, E.P.1
  • 45
    • 0030219832 scopus 로고    scopus 로고
    • Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study
    • E.P. DeAntoni, E.D. Crawford, and J.E. Oesterling Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study Urology 48 2 1996 234 239
    • (1996) Urology , vol.48 , Issue.2 , pp. 234-239
    • Deantoni, E.P.1    Crawford, E.D.2    Oesterling, J.E.3
  • 46
    • 0033575051 scopus 로고    scopus 로고
    • Cancer surveillance series: Interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
    • B.F. Hankey, E.J. Feuer, and L.X. Clegg Cancer surveillance series: interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates J Natl Cancer Inst 91 12 1999 1017 1024
    • (1999) J Natl Cancer Inst , vol.91 , Issue.12 , pp. 1017-1024
    • Hankey, B.F.1    Feuer, E.J.2    Clegg, L.X.3
  • 47
    • 4143148652 scopus 로고    scopus 로고
    • Prostate-specific antigen: A review of the validation of the most commonly used cancer biomarker
    • J. Hernandez, and I.M. Thompson Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker Cancer 101 2004 894 904
    • (2004) Cancer , vol.101 , pp. 894-904
    • Hernandez, J.1    Thompson, I.M.2
  • 48
    • 1442347508 scopus 로고    scopus 로고
    • American Cancer Society. Cancer facts and figures, 2004. Available at: http://www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf. Accessed July 18, 2005.
    • (2004) Cancer Facts and Figures
  • 49
    • 0032412862 scopus 로고    scopus 로고
    • The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States
    • J.M. Legler, E.J. Feuer, and A.L. Potosky The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States Cancer Causes Control 9 1998 519 527
    • (1998) Cancer Causes Control , vol.9 , pp. 519-527
    • Legler, J.M.1    Feuer, E.J.2    Potosky, A.L.3
  • 50
    • 0037163481 scopus 로고    scopus 로고
    • Cancer survival among US whites and minorities: A SEER (Surveillance, Epidemiology, and End Results) Program population-based study
    • L.X. Clegg, F.P. Li, and B.F. Hankey Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study Arch Intern Med 162 2002 1985 1993
    • (2002) Arch Intern Med , vol.162 , pp. 1985-1993
    • Clegg, L.X.1    Li, F.P.2    Hankey, B.F.3
  • 51
    • 18244394843 scopus 로고    scopus 로고
    • Screening for prostate cancer: Updated experience from the Tyrol study
    • W. Horninger, A. Berger, and A. Pelzer Screening for prostate cancer: updated experience from the Tyrol study Can J Urol 12 Suppl 1 2005 7 13
    • (2005) Can J Urol , vol.12 , Issue.1 SUPPL. , pp. 7-13
    • Horninger, W.1    Berger, A.2    Pelzer, A.3
  • 52
    • 20144368657 scopus 로고    scopus 로고
    • Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: Findings from the initial screening round of a randomized trial
    • G.L. Andriole, D.L. Levin, E.D. Crawford, and the PLCO Project Team Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial J Natl Cancer Inst 97 6 2005 433 438
    • (2005) J Natl Cancer Inst , vol.97 , Issue.6 , pp. 433-438
    • Andriole, G.L.1    Levin, D.L.2    Crawford, E.D.3    Plco Project Team, T.4
  • 53
    • 1242296763 scopus 로고    scopus 로고
    • Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: Results of second screening round of ERSPC (Rotterdam)
    • M.J. Roobol, R. Kranse, and H.J. de Koning Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (Rotterdam) Urology 63 2 2004 309 313
    • (2004) Urology , vol.63 , Issue.2 , pp. 309-313
    • Roobol, M.J.1    Kranse, R.2    De Koning, H.J.3
  • 54
    • 0027244510 scopus 로고
    • The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
    • W.A. Sakr, G.P. Haas, and B.F. Cassin The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients J Urol 150 2 Pt 1 1993 379 385
    • (1993) J Urol , vol.150 , Issue.2 PART 1 , pp. 379-385
    • Sakr, W.A.1    Haas, G.P.2    Cassin, B.F.3
  • 55
    • 3042715631 scopus 로고    scopus 로고
    • Serum protein expression profiling for cancer detection: Validation of a SELDI-based approach for prostate cancer
    • W.E. Grizzle, B.L. Adam, and W.L. Bigbee Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer Dis Markers 19 4-5 2004 185 195
    • (2004) Dis Markers , vol.19 , Issue.4-5 , pp. 185-195
    • Grizzle, W.E.1    Adam, B.L.2    Bigbee, W.L.3
  • 56
    • 19944419092 scopus 로고    scopus 로고
    • Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility
    • O.J. Semmes, Z. Feng, and B.L. Adam Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility Clin Chem 51 1 2005 102 112
    • (2005) Clin Chem , vol.51 , Issue.1 , pp. 102-112
    • Semmes, O.J.1    Feng, Z.2    Adam, B.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.